UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Regeneron Pharmaceuticals
REGN
$82.7B
| $267M | 0.07% |
254,461
-3,020
| -1% | -$2.93M |
|
277
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
| $267M | 0.07% |
1,163,038
+3,540
| +0.3% | +$812K |
|
278
iShares Core Dividend Growth ETF
DGRO
$43.8B
| $265M | 0.07% |
4,597,784
+536
| +0% | +$30.6K |
|
279
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
| $265M | 0.07% |
4,210,005
+69,650
| +2% | +$4.06M |
|
280
CALL
CrowdStrike
CRWD
$221B
| $261M | 0.06% |
2,720,296
+1,176,584
| +76% | +$97.8M |
|
281
iShares Semiconductor ETF
SOXX
$46.5B
| $258M | 0.06% |
1,046,952
+101,619
| +11% | +$23.3M |
|
282
Johnson Controls International
JCI
$93.1B
| $256M | 0.06% |
3,847,972
+1,655,792
| +76% | +$111M |
|
283
PUT
Morgan Stanley
MS
$342B
| $255M | 0.06% |
2,628,300
-1,260,800
| -32% | -$120M |
|
284
Synopsys
SNPS
$80.7B
| $253M | 0.06% |
425,918
+20,822
| +5% | +$11.8M |
|
285
Amphenol
APH
$206B
| $251M | 0.06% |
3,728,246
+344,826
| +10% | +$21.8M |
|
286
Southwest Airlines
LUV
$21.7B
| $251M | 0.06% |
8,769,405
+7,574,970
| +634% | +$211M |
|
287
iShares Russell Mid-Cap Growth ETF
IWP
$21.1B
| $249M | 0.06% |
2,255,850
-42,444
| -2% | -$4.66M |
|
288
FedEx
FDX
$79.2B
| $248M | 0.06% |
827,534
+56,714
| +7% | +$14.8M |
|
289
General Dynamics
GD
$107B
| $248M | 0.06% |
854,320
-8,879
| -1% | -$2.6M |
|
290
Targa Resources
TRGP
$59.1B
| $247M | 0.06% |
1,918,590
+70,048
| +4% | +$8.2M |
|
291
PUT
iShares China Large-Cap ETF
FXI
$4.16B
| $247M | 0.06% |
9,501,700
+5,421,400
| +133% | +$142M |
|
292
MPLX
MPLX
$60.3B
| $244M | 0.06% |
5,740,296
-649,693
| -10% | -$26.7M |
|
293
CALL
Intel
INTC
$542B
| $242M | 0.06% |
7,807,081
-2,058,826
| -21% | -$67.5M |
|
294
3M
MMM
$94.2B
| $242M | 0.06% |
2,364,042
-911,678
| -28% | -$88.9M |
|
295
PUT
Qualcomm
QCOM
$174B
| $241M | 0.06% |
1,211,500
+367,300
| +44% | +$69.4M |
|
296
Paychex
PAYX
$43.4B
| $241M | 0.06% |
2,030,136
-101,507
| -5% | -$12.4M |
|
297
Pinduoduo
PDD
$121B
| $239M | 0.06% |
1,800,235
-345,805
| -16% | -$46.8M |
|
|
FISV
298
Fiserv Inc
FISV
$28.9B
| $238M | 0.06% |
1,597,307
+83,445
| +6% | +$12.6M |
|
299
CALL
JPMorgan Chase
JPM
$964B
| $236M | 0.06% |
1,168,270
-346,732
| -23% | -$67.8M |
|
300
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
| $231M | 0.06% |
1,535,047
-14,070
| -0.9% | -$2.14M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,228 new, 3,687 increased, 4,131 reduced and 1,041 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,228 new positions and closed 1,041 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.